Task: Answer the following question about the molecule with SMILES COCCOCCCC(=O)NCCCC[C@H](N)C(=O)O.
Description: Please describe this drug.
Answer: Pegvorhyaluronidase alfa is under investigation in clinical trial NCT02241187 (Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection).
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
COCCOCCCC(=O)NCCCC[C@H](N)C(=O)O
COCCOCCCC(=O)NCCCC[C@@H](C(=O)O)N
(2S)-2-amino-6-[4-(2-methoxyethoxy)butanoylamino]hexanoicacid
Please describe this drug.
Pegvorhyaluronidase alfa is under investigation in clinical trial NCT02241187 (Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection).